World Cancer Day 2021
4th February marks World Cancer Day 2021, this global initiative is led by the Union for International Cancer Control (UICC) is dedicated to raising awareness and improving education surrounding cancer and ensuring treatment is globally available. Biorex Diagnostics are proud to continue their commitment to investing in extensive research and development in a range of diagnostic cancer tests. Each year, Biorex Diagnostics invest 30% of annual turnover towards the research & development of custom tests including early cancer detection. The tests will assist clinicians to identify the presence of cancer on average four years before standard clinical diagnosis. Unlike the tumour antigens themselves,
Antibody Testing with Biorex Diagnostics
As the Covid-19 pandemic continues to unfold there is a growing interest in antibody testing and its benefits. Antibody tests are used to detect the presence of antibodies to SARS-CoV-2 to determine if it’s likely that an individual has had the virus and recovered, this test method is believed to be the best way to assess past exposure to the virus. The key benefits to antibody testing are: Determining if antibodies are present allows for further research to be conducted into potential periods of immunity post infection and how long this could last. Experts can gain a deeper insight into how
98.6% Specificity on Biorex Test
Biorex Tests help things return to "Normal" As more and more people seek to return to ‘normal life’ Biorex tests will be invaluable to the success of helping schools and university’s remain open, corporate businesses returning to the office, health workers avoiding quarantine, increased protection in our care homes and future airport control. Biorex antibody test has been hugely responsible for the success of the track and trace study being carried out across England. Data of over 200k participants shows 97% successfully completed their test following the guides and up to 94% had a valid result. This data is testament to fortress
Antigen Tests Now Available
Biorex Diagnostics have taken their testing to a new level introducing the new Ag Rapid test. It offers quicker results for more efficient and effective treatment of Sars-CoV-2. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Rapid diagnosis of SARS-CoV-2 infection will help healthcare professionals to treat patients and control the disease more efficiently and effectively. Benefits Rapid testing for SARS-CoV-2 antigen within 15 minutes Facilitates patient treatment decisions quickly Simple, time-saving procedure All necessary reagents provided & no equipment needed High sensitivity and specificity Specification Result time 15 minutes Storage 2-30°C Shelf Life 24 Months
Dental Practices using the Biorex Antibody test
General dental practitioners have been limited to providing non-AGPs to non-COVID-19 patients with an urgent dental care need. Throughout this crisis period, many such patients have continued to receive face to face care in general dental practices. This has been a key element of ensuring that the urgent oral health needs of the Northern Ireland population have been met. While it has been absolutely necessary to limit the number of patients seen in general dental practice in order to minimise the risk of Coronavirus transmission, this has unfortunately meant that there are a significant and growing number of patients with pressing
Worldwide, 300 million people are living with viral hepatitis unaware
Worldwide, 300 million people are living with viral hepatitis unaware. Without finding the undiagnosed and linking them to care, millions will continue to suffer, and lives will be lost. On World Hepatitis Day, 28 July, we call on people from across the world to take action and raise awareness to find the “missing millions”. One of just four disease-specific global awareness days officially endorsed by the World Health Organization (WHO), WHD unites patient organisations, governments, medical professionals, civil society, industry and the general public to boost the global profile of viral hepatitis. World Hepatitis Day, 28 July, is an opportunity to step
Total Antibody – IgM / IgG
Covid-19 Total Antibody - IgM / IgG Biorex COVID-19 Total Ab Device is a single use, rapid device for qualitative detection of total antibodies against 2019 novel coronavirus (SARS-CoV-2) in human serum, plasma or whole blood specimens. The kit is intended for screening of patients suspected for infection with SARS-CoV-2, and as an aid in the diagnosis of the coronavirus disease 2019 (COVID-19). Rapid Test Key Features: • High quality & easy-to-use. • Quick results – Within 10 min • Little or no additional equipment required • Possibility to store at room temperature for extended length of time. Two Step Process 1. 5-10 μl
Bleeding Disorders Associated with COVID-19
Biorex Diagnostics would like to advise of the guidelines on bleeding disorders associated with COVID-19 recently released by the International Society of Thrombosis and Haemostasis (ISTH). Many severely ill patients initially present with single organ failure (i.e. respiratory insufficiency) but some of them progress to more systemic disease and multiple organ dysfunction. Based on the currently available literature, ISTH would recommend measuring D-dimers, prothrombin time and platelet count in all patients who present with COVID-19 infection. As well as offering Covid-19 Tests as ELISA, Rapid and PCR - Biorex Diagnostics offer the following products that meet ISTH guidlines. D-Dimer Catalogue Number Description Size Details BXC0787A Immunoturbidimetric Multipoint Calibration R1: 1 x
Real-Time PCR Test Now Available
Given the nature of the disease as a viral pathogen, the optimal diagnostic tool to evaluate the presence of the viral particle is Real-Time PCR. This virus encapsulates an RNA template that is the target for diagnosis. It is most efficient to carry out Real-Time PCR experiments on RNA samples with one-step methodology. United States CDC has issued a recommendation for designing Molecular Diagnostic kits based on RT-qPCR which has shown to be successful in detecting the viral pathogen and has been implemented worldwide as a reference in the diagnosis of the disease. We, at the Biorex Department of Molecular Diagnostics, have
COVID-19 Coronavirus – New Rapid Test
To efficiently respond to the COVID-19 (SARS-CoV-2) epidemic, rapid detection of cases and contacts, appropriate clinical management and infection control, are critical. This can best be achieved with wide availability of testing capabilities in health care settings and commercial laboratories. For this reason Biorex Food Diagnostics have developed and manufactured a new test that detects the new strain of COVID-19 (Coronavirus). The new strain of the virus infects the respiratory system and may cause pneumonia. This test enables quick and informed treatment decisions to be made at the point of care. Elisa Test Key Features: Highly sensitive, specific Affordable and long shelf